Earnings · China A-shares
Zhejiang CONBA Pharmaceutical Co., Ltd. Class A (600572) earnings
Zhejiang CONBA Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -3.02% year on year, +40.35% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +0.96% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -3.02%
- Excl. one-offs YoY
- +40.35%
- Net profit QoQ
- +5.20%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.24% | — |
| 3 days | +0.96% | — |
| 7 days | +4.32% | — |
| 14 days | +0.00% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 3 of 7 reports (average +0.45%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥566.41M | -3.02% | +40.35% | +7.12% | 0.22 | 7.89% | +0.96% | — | — |
| 2026 interim report | 2026-08-26 | ¥377.77M | +6.83% | +43.38% | +10.21% | 0.15 | 5.26% | +4.65% | +1.86% | +8.85% |
| 2026 Q1 report | 2026-04-23 | ¥198.45M | +4.78% | +28.74% | +13.10% | 0.08 | 2.77% | -3.70% | -10.65% | -9.10% |
| 2025 annual report | 2026-04-23 | ¥474.36M | -23.79% | -27.67% | -0.64% | 0.19 | 6.86% | -3.70% | -10.65% | -9.10% |
| 2025 Q3 report | 2025-10-29 | ¥584.03M | +12.65% | +1.61% | +1.27% | 0.23 | 8.05% | +5.17% | +3.82% | +7.29% |
| 2025 interim report | 2025-08-28 | ¥353.61M | -7.48% | -11.86% | -2.61% | 0.14 | 5.05% | -0.66% | -1.54% | -7.04% |
| 2025 Q1 report | 2025-04-29 | ¥189.40M | -12.34% | -19.35% | -7.64% | 0.07 | 2.66% | -3.29% | +0.88% | -1.70% |
| 2024 annual report | 2025-04-25 | ¥622.42M | +5.21% | -6.77% | -3.23% | 0.25 | 9.12% | +0.00% | +4.72% | +1.47% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.